Related Experiment Video

Updated: Jul 6, 2026

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
09:00

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance

Published on: May 2, 2018

Risks of extended-spectrum beta-lactamases

    Drug and Therapeutics Bulletin
    |March 14, 2008
    PubMed

    Insights

    Extended-spectrum beta-lactamase (ESBL) producing bacteria are a growing global threat, causing difficult-to-treat infections in hospitals and communities. This review discusses these resistant organisms and their treatment strategies.

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Antimicrobial Resistance

    Background:

    • Extended-spectrum beta-lactamases (ESBLs) are enzymes that confer multi-drug resistance in bacteria.
    • ESBL-producing organisms are a significant cause of healthcare-associated infections.
    • There is a concerning increase in community-acquired infections, particularly urinary tract infections, caused by ESBL-producing bacteria.

    Purpose of the Study:

    • To discuss bacteria that produce ESBLs.
    • To review the treatment of patients infected with ESBL-producing organisms.

    Main Methods:

    • Literature review of studies on ESBL-producing bacteria and their treatment.
    • Synthesis of current knowledge on the epidemiology and clinical management of ESBL infections.

    Main Results:

    • ESBL-producing bacteria are an increasing global cause of difficult-to-treat infections.
    • These infections pose a major threat to life and increase healthcare costs.
    • Treatment of ESBL infections can be challenging and may lead to prolonged hospital stays.

    Conclusions:

    • ESBL-producing bacteria represent a significant and growing challenge in infectious disease management.
    • Effective treatment strategies are crucial for improving patient outcomes and reducing the burden of these infections.

    More Related Videos

    Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing08:19

    Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

    Published on: July 7, 2020

    Related Concept Videos

    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Inhibitors of Gram-positive Cell Wall Synthesis01:23

    Inhibitors of Gram-positive Cell Wall Synthesis

    Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
    Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

    Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

    Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
    Development of Antibiotic Resistance01:30

    Development of Antibiotic Resistance

    Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
    Antibiotic Selection00:57

    Antibiotic Selection

    Overview